Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Subscribe
Providers
Hospitals
Practices
Retail
Health Tech
AI and Machine Learning
Digital Health
Telehealth
Payers
Regulatory
Finance
Special Reports
Fierce 50
Special Report
Awards Gala
Awards
DEI Awards
Innovation Awards
Resources
Webinars
Fierce Events
Industry Events
Podcasts
Survey
Whitepapers
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Tune in to Podnosis: The watchdog overseeing the integrity of HHS programs
mifepristone
Fierce Pharma
FDA is moving forward with abortion pill safety study: WSJ
The FDA isĀ investigating the safety of mifepristone, an initiative that could allow the administration to impose restrictions on its use, WSJ reports.
Kevin Dunleavy
Jun 5, 2026 11:06am
Fierce Pharma
SCOTUS temporarily restores telehealth access to abortion pill
May 15, 2026 11:20am
Fierce Pharma
Abortion pill producers ask SCOTUS to prevent online access ban
May 4, 2026 12:05pm
Fierce Pharma
FDA takes close look at mifepristone REMS program
Sep 25, 2025 11:00am
Fierce Biotech
Biotech leaders urge FDA to not restrict abortion pill access
Jul 2, 2025 2:14pm
Fierce Pharma
Four states ask FDA to lift restrictions on mifepristone
Jun 6, 2025 8:21am